<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM/HYPOTHESIS: We investigated the effects of the common polymorphisms in the peroxisome proliferator-activated receptor gamma2 (PPAR-gamma2; Pro12Ala) and in PPAR-gamma coactivator 1alpha (<z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha; Gly482Ser) genes on the conversion from <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in participants in the STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp> trial </plain></SENT>
<SENT sid="1" pm="."><plain>This trial aimed to study the effect of <z:chebi fb="0" ids="2376">acarbose</z:chebi> in the prevention of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Genotyping was performed in 770 study subjects whose DNA was available </plain></SENT>
<SENT sid="3" pm="."><plain>The Gly482Ser variant in the <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha gene was determined with the polymerase chain reaction amplification, Hpa II enzyme digestion, and gel electrophoresis </plain></SENT>
<SENT sid="4" pm="."><plain>The Pro12Ala polymorphism of the PPAR-gamma2 gene was determined by the polymerase chain reaction-single-strand conformation polymorphism analysis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The Pro12Pro genotype of the PPAR-gamma2 gene predicted the conversion to <z:mp ids='MP_0002055'>diabetes</z:mp> in women in the <z:chebi fb="0" ids="2376">acarbose</z:chebi> group (odds ratio 2.89, 95% CI 1.20 to 6.96; p=0.018) </plain></SENT>
<SENT sid="6" pm="."><plain>The 482Ser allele of the <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha gene had a significant interaction with the mode of treatment (p=0.012), and in the placebo group the 482Ser allele was associated with a 1.6-fold higher risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> compared to the Gly482Gly genotype (95% CI 1.06 to 2.33; p=0.023) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="2376">Acarbose</z:chebi> prevented the development of <z:mp ids='MP_0002055'>diabetes</z:mp> independently of the genotype of the PPAR-gamma2 gene, but only the carriers of the 482Ser allele of the <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha gene were responsive to <z:chebi fb="0" ids="2376">acarbose</z:chebi> treatment </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION/INTERPRETATION: We conclude that the Pro12Pro genotype of the PPAR-gamma2 gene and the 482Ser allele of the <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha gene are associated with the conversion from <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp> trial </plain></SENT>
</text></document>